glp-1 stomach paralysis Ozempic, Wegovy linked to cases of paralysis, new research shows Weight loss: GLP-1 agonists may

However, Wegovy (the same semaglutide molecule at weight-loss doses) is FDA-approved for chronic weight management

No significant abnormalities in behavior, weight, or organ histology were observed after standard experimental administration (2)

GSH is carried in the bile to the intestinal luminal compartment

LA deficiency leads to an impaired more permeable skin barrier and the topical application of LA-rich sunflower oil can fix this issue rapidly (while oleic-rich olive oil did not have the same barrier repairing effect)

Positive outcomes in rodents do not automatically translate into safe and effective therapies for people

Short hair allows adequate skin cleaning without complications